<unk>  is an antihemophilic factor that is FDA approved for the prevention of bleeding episodes in adult and pediatric patients with hemophilia B and peri-operative management in adult and pediatric patients with hemophilia B.   Common adverse reactions include nausea, injection site reaction, injection site pain, headache, dizziness and rash.
Coagulation factor IX
Coagulation factor VIIa
Factor IX complex
Antithrombin III
Thrombus precursor protein 
Coagulation factor XIII A-subunit
Factor ix complex
Antihemophilic Factor 